Stories

There is too much emotion driving public policy on e-cigarettes, says leading tobacco control researcher Dr. Jasjit Ahluwalia. A physician, public health scientist, and professor at Brown University’s Schools of Public Health and Medicine, Dr. Ahluwalia has deep experience researching health disparities and smoking cessation and nicotine addiction in African-American smokers. He has been continuously funded by the NIH for 25 years and has published over 400 manuscripts. Hear his assessment on the efficacy and relative safety of e-cigarettes and other safer nicotine products.

A comprehensive new analysis has found that nicotine e-cigarettes, varenicline and cytisine are the most effective options currently available for helping smokers quit long-term (going at least six months without smoking). This is closely followed by using two forms of nicotine replacement therapy at the same time, such as a nicotine patch alongside gum, lozenges, or nasal sprays. [...] "Our research dives deep into the world of smoking cessation. By pulling together data from hundreds of studies and over 150,000 people, we can see that when people use the medicines licenced for quitting smoking or nicotine e-cigarettes, they are more likely to quit than if they do not use these aids. [...]

Drinking some tea and coffee does not harm babies, but smoking is twice as bad as previously thought, according to new research. The NHS recommends that pregnant women should drink no more than 200mg of caffeine a day, equivalent to two cups of instant coffee or tea. They should also stop smoking. This is because drinking large amounts of caffeine and smoking have been associated with increased risk of pregnancy complications, premature birth and foetal growth restriction.

Over 375 US localities and 7 states have adopted permanent restrictions on sales of flavored electronic nicotine delivery systems (“ENDS”). These policies’ effects on combustible cigarette use (“smoking”), a more lethal habit, remain unclear. Matching new flavor policy data to retail sales data, we find a tradeoff of 15 additional cigarettes for every 1 less 0.7 mL ENDS pod sold due to ENDS flavor restrictions. Further, cigarette sales increase even among brands disproportionately used by underage youth. Thus, any public health benefits of reducing ENDS use via flavor restrictions may be offset by public health costs from increased cigarette sales.

Philip Morris International (PMI) has registered new lobbyists in at least 19 US states this year, and plans to add some in four more in the next two weeks, according to a review of public records and information provided by the company. The world’s biggest cigarette maker by market value is expanding its lobbying firepower as it prepares to launch its flagship IQOS heated tobacco device in a long-awaited entry to the US, where vaping already is an established alternative to smoking.

Lawmakers in the Bay State recently heard testimony on proposals in both the Massachusetts House and Senate which seek to address youth nicotine addiction by increasing the state excise taxes on cigars and cigarettes. While protecting youth from all age-restricted products is laudable, Massachusetts youth are reporting record lows in cigarette and cigar use. Rather than imposing draconian taxes that will disproportionately impact lower-income persons, and stoke fears of a youth vaping epidemic that doesn’t exist, lawmakers should utilize existing tobacco monies on programs to address youth use of tobacco and vapor products.